Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-03 Alkalinisation of urine
| Citric acid with potassium citrate |
|
Formulary
|
Effervescent tablets citric acid 250 mg, Potassium citrate 1.5 gram (Effercitrate®)
Mixture BP potassium citrate 30% |
|
Links
FSRH Clinical Guideline: Contraceptive Choices for Young People- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
LSCMMG: Erectile Dysfunction Guideline- LSCMMG: Overactive bladder in female adults
- MHRA: Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management
- NICE TA610: Pentosan polysulfate sodium for treating bladder pain syndrome
- NICE TA610: Pentosan polysulfate sodium for treating bladder pain syndrome
- NICE TA838: Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)